| ²é¿´: 503 | »Ø¸´: 1 | |||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | |||
ÀËÇéÎÞÇéÒø³æ (ÕýʽдÊÖ)
|
[ÇóÖú]
Çë¸ßÊÖÃǰïæ·Òëһƪ¡¶ÉùÃ÷¡·ÎÄÊé
|
||
|
Éù Ã÷ ±¾ÉùÃ÷È·ÈÏ£¬±¾¹«Ë¾001×ÔÖ÷Ñз¢µÄÓµÓÐרÀûµÄÑÎËáÄÉÂåͪÊÇÓÚµ±µØ002Éú²ú£¬ÎÒÃÇÊÚȨ003¹«Ë¾Ê¹ÓÃÎÒÃÇ×ÔÖ÷Ñз¢²¢ÓµÓÐרÀûµÄ004ÒÔÅ·ÖÞ±ê×¼Éú²úƿװ004×¢ÉäÒººÍ×¢ÉäÓÃ004£¨¶³¸É·Û£©£¬²¢½öÏÞÓÚ¶À¼ÒÉú²úÓÃ;¡£ ±¾ÉùÃ÷ÊÚȨ²»¿É±»Èκλú¹¹ÓÃÓÚתÊÛ¡£ ×î³ÏÖ¿µÄÎʺò |
» ²ÂÄãϲ»¶
085501»úеר˶ 302·Ö ²»ÌôרҵÇóµ÷¼Á
ÒѾÓÐ3È˻ظ´
332£¬085601Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
292Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
314Çóµ÷¼Á
ÒѾÓÐ17È˻ظ´
Ò»Ö¾Ô¸Öйú¿ÆÑ§ÔºÉϺ£ÓлúËù£¬Óлú»¯Ñ§356·ÖÕÒµ÷¼Á
ÒѾÓÐ6È˻ظ´
291Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
¿¼ÑжþÂÖµ÷¼Á
ÒѾÓÐ4È˻ظ´
262Çóµ÷¼Á
ÒѾÓÐ13È˻ظ´
µ÷¼Á
ÒѾÓÐ17È˻ظ´
268·Ö085602»¯Ñ§¹¤³Ìµ÷¼Á
ÒѾÓÐ14È˻ظ´

thorny_rose
½ð³æ (СÓÐÃûÆø)
- ·ÒëEPI: 27
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 659.4
- ºì»¨: 2
- Ìû×Ó: 85
- ÔÚÏß: 20Сʱ
- ³æºÅ: 1802186
- ×¢²á: 2012-05-07
- ÐÔ±ð: MM
- רҵ: Íâ¹úÓïÑÔ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
sltmac: ½ð±Ò+1 2012-06-27 22:27:38
ÀËÇéÎÞÇé: ½ð±Ò+15, ·ÒëEPI+1, ¡ïÓаïÖú 2012-06-28 10:19:50
sltmac: ½ð±Ò+1 2012-06-27 22:27:38
ÀËÇéÎÞÇé: ½ð±Ò+15, ·ÒëEPI+1, ¡ïÓаïÖú 2012-06-28 10:19:50
|
ºÜ±§Ç¸£¬²»ÊǸßÊÖ£¬ÒÔÏÂÒëÎĽö¹©²Î¿¼ ¡¾Òë¡¿Statement The statement confirmed that the independent research and development of the company¡¯s patented naloxone hydrochloride are produced in the local 002. We authorize 003 companies use our own R & D and patented 004 to produce bottled 004 injection and frozen powder by European standards, and which is limited to an exclusive production use. This statement authorization can not be used by any organization for resale. Sincerely yours, |

2Â¥2012-06-27 21:11:15













»Ø¸´´ËÂ¥